The US FDA has declined to approve the NDA submitted by Vanda Pharmaceuticals for tradipitant to treat gastroparesis symptoms ...

RxCell has received a US patent for an iPSC-based cell therapy approach, a method of generating multiple cellular therapy ...

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended an update to Novo Nordisk’s ...

The NHS England has announced the routine commissioning of Daiichi Sankyo's quizartinib for acute myeloid leukaemia (AML).

The Outsourcing in Clinical Trials New England conference will gather pharma experts to discuss the current clinical trial ...

NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...

As part of the acquisition, Organon will acquire psoriasis treatment Vtama, which could soon be approved in atopic dermatitis ...

Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for treating eosinophilic granulomatosis with ...

Ossium Health is also running the PRESERVE I trial to evaluate the safety and effectiveness of its deep-frozen bone marrow ...

Statistics show incidences of cancer are rising in younger demographics. Tailored therapies offer a solution - if clinical ...

Accord BioPharma received FDA approval for 420mg HERCESSI, a biosimilar to Herceptin to treat various kinds of ...

Lupin has announced a non-exclusive patent licence agreement with Takeda for the commercialisation of Vonoprazan Tablets in ...